Susceptibility test methods: Dilution and disk diffusion methods

Manual of Clinical Microbiology: Tenth Edition

Volumn 1-2, Issue , 2022, Pages 1122-1143

  Patel, Jean B ^a   Tenover, Fred C ^b   Turnidge, John D ^c   Jorgensen, James H ^d  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CEPHEID   (United States)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^d University of Texas Health Science Center   (United States)

Author keywords

Antimicrobial susceptibility testing; CLSIreference method; Dilution methods; Disk diffusion methods

Indexed keywords

EID: 85188864826     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1128/9781555816728.ch68     Document Type: Chapter

References (83)

1. Andrews, J. M., for the BSAC Working Party on Susceptibility Testing. 2001. BSAC standardized disc susceptibility testing method. J. Antimicrob. Chemother. 48(Suppl. 1):43-57.
2. Andrews, J. M. 2001. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48(Suppl. 1):5-16.
3. Andrews, J. M., F. J. Boswell, and R. Wise. 2000. Evaluation of the Oxoid Aura image system for measuring zones of inhibition with the disc diffusion technique. J. Antimicrob. Chemother. 46:535-540.
4. Baker, C. N., S. A. Stocker, D. H. Culver, and C. Thornsberry. 1991. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J. Clin. Microbiol. 29:533-538.
5. Barry, A. L., R. E. Badal, and R. W. Hawkinson. 1983. Influence of inoculum growth phase on microdilution susceptibility tests. J. Clin. Microbiol. 18:645-651.
6. Barry, A. L., L. B. Reller, G. H. Miller, J. A. Washington, F. D. Schoenknect, L. R. Peterson, R. S. Hare, and C. Knapp. 1992. Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides. J. Clin. Microbiol. 30:585-589.
7. Bauer, A. W., W. M. Kirby, J. C. Sherris, and M. Turck. 1966. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 45:493-496.
8. Bauer, A. W., and J. C. Sherris. 1964. The determination of sulfonamide susceptibility of bacteria. Chemotherapy 15:1-19.
9. Bell, S. M. 1988. Additions and modifications to the range of antibiotics tested by the CDS method of antibiotic sensitivity testing. Pathology 20:303-304.
10. Bell, S. M. 1975. The CDS disc method of antibiotic sensitivity testing (calibrated dichotomous sensitivity test). Pathology 7(Suppl.):1-48.
11. Berke, I., and P. M. Tierno, Jr. 1996. Comparison of efficacy and cost-effectiveness of BIOMIC VIDEO and Vitek antimicrobial susceptibility test systems for use in the clinical microbiology laboratory. J. Clin. Microbiol. 34:1980-1984.
12. Brenner, V. C., and J. C. Sherris. 1972. Influence of different media and bloods on results of diffusion antibiotic susceptibility tests. Antimicrob. Agents Chemother. 1:116-122.
13. British Society for Antimicrobial Chemotherapy. 1991. A guide to sensitivity testing. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. J. Antimicrob. Chemother. 27(Suppl. D):1-50.
14. Brown, D. F. 1990. The comparative methods of antimicrobial susceptibility testing-time for a change? J. Antimicrob. Chemother. 25:307-310.
15. Brown, D. F. J. 1994. Developments in antimicrobial susceptibility testing. Rev. Med. Microbiol. 5:65-75.
16. Brunden, M. N., G. E. Zurenko, and B. Kapik. 1992. Modification of the error-rate bounded classification scheme for use with two MIC break points. Diagn. Microbiol. Infect. Dis. 15:135-140.
17. Chaitram, J. M., L. A. Jevitt, S. Lary, and F. C. Tenover. 2003. The World Health Organization's External Quality Assurance System Proficiency Testing Program has improved the accuracy of antimicrobial susceptibility testing and reporting among participating laboratories using NCCLS methods. J. Clin. Microbiol. 41:2372-2377.
18. Clinical and Laboratory Standards Institute. 2008. Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters. Approved guideline M23-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
19. Clinical and Laboratory Standards Institute. 2006. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. Proposed guideline M45-P. Clinical and Laboratory Standards Institute, Wayne, PA.
20. Clinical and Laboratory Standards Institute. 2009. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 8th ed. Approved standard M7-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
21. Clinical and Laboratory Standards Institute. 2009. Performance Standards for Antimicrobial Disk Susceptibility Tests, 10th ed. Approved standard M2-A10. Clinical and Laboratory Standards Institute, Wayne, PA.
22. Clinical and Laboratory Standards Institute. 2010. Performance Standards for Antimicrobial Susceptibility Testing. Nineteenth informational supplement. M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
23. Clinical and Laboratory Standards Institute. 2006. Protocols for Evaluating Dehydrated Mueller-Hinton Agar. Approved standard M6-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
24. Clinical and Laboratory Standards Institute/NCCLS. 2001. Evaluation of Lots of Dehydrated Mueller-Hinton Broth for Antimicrobial Susceptibility Testing. Proposed guideline M23-P, vol. 21. NCCLS, Wayne, PA.
25. Coyle, M. B., M. F. Lampe, C. L. Aitken, P. Feigl, and J. C. Sherris. 1976. Reproducibility of control strains for antibiotic susceptibility testing. Antimicrob. Agents Chemother. 10:436-440.
26. Daly, J. S., R. A. Dodge, R. H. Glew, D. T. Soja, B. A. DeLuca, and S. Hebert. 1997. Effect of zinc concentration in Mueller-Hinton agar on susceptibility of Pseudomonas aeruginosa to imipenem. J. Clin. Microbiol,. 35:1027-1029.
27. D'Amato, R. F., C. Thornsberry, C. N. Baker, and L. A. Kirven. 1975. Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin [sic] polymyxin B, and carbenicillin. Antimicrob. Agents Chemother. 7:596-600.
28. de Lencastre, H., A. M. Sa Figueiredo, C. Urban, J. Rahal, and A. Tomasz. 1991. Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 35:632-639.
29. Deutsches Institut für Normung. 2002. Susceptibility Testing of Pathogens to Antimicrobial Agents, part 3. Agar Diffusion Test, vol. DIN 58940-3. Beuth Verlag, Berlin, Germany.
30. Deutsches Institut für Normung. 2003. Susceptibility Testing of Pathogens to Antimicrobial Agents, part 6. Determination of the Minimum Inhibitory Concentration (MIC) with the Agar Dilution Method, vol. DIN 58940-6. Beuth Verlag, Berlin, Germany.
31. Diekema, D. J., K. Lee, P. Raney, L. A. Herwaldt, G. V. Doern, and F. C. Tenover. 2004. Accuracy and appropriateness of antimicrobial susceptibility test reporting for bacteria isolated from blood cultures. J. Clin. Microbiol. 42:2258-2260.
32. Doern, G. V. 1987. Breakpoint susceptibility testing. Clin. Microbiol. Newsl. 9:81-84.
33. Ericsson, H. M., and J. C. Sherris. 1971. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol. Microbiol. Scand. Sect. B Suppl. 217:1-90.
34. European Committee for Antimicrobial Susceptibility Testing. 2000. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin. Microbiol. Infect. 6:509-515.
35. Ferraro, M. J. 2001. Should we reevaluate antibiotic breakpoints? Clin. Infect. Dis. 33(Suppl. 3):S227-S229.
36. Fiebelkorn, K. R., S. A. Crawford, M. L. McElmeel, and J. H. Jorgensen. 2003. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J. Clin. Microbiol. 41:4740-4744.
37. Fuchs, P. C., A. L. Barry, and S. D. Brown. 2000. Daptomy- cin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests. Diagn. Microbiol. Infect. Dis. 38:51-58.
38. Gales, A. C., A. O. Reis, and R. N. Jones. 2001. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J. Clin. Microbiol. 39:183-190.
39. Hayden, M. K., K. Rezai, R. A. Hayes, K. Lolans, J. P. Quinn, and R. A. Weinstein. 2005. Development of dapto- mycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43:5285-5287.
40. Health Care Financing Administration. 1992. Clinical Laboratory Improvement Amendments of 1988, final rule. Fed. Regist. 57:7001-7186.
41. Huang, M. B., C. N. Baker, S. Banerjee, and F. C. Tenover. 1992. Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents. J. Clin. Microbiol. 30:3243-3248.
42. Huang, M. B., T. E. Gay, C. N. Baker, S. N. Banerjee, and F. C. Tenover. 1993. Two percent sodium chloride is required for susceptibility testing of staphylococci with oxacillin when using agar-based dilution methods. J. Clin. Microbiol. 31:2683-2688.
43. International Organization for Standardization. 2006. Susceptibility Testing of Infectious Agents and Evaluation of Performance of Antimicrobial Susceptibility Devices, part 1. Reference Method for Testing the In Vitro Activity of Antimicrobial Agents against Bacteria Involved in Infectious Diseases, vol. ISO/DIS 20776-1. International Organization for Standardization, Geneva, Switzerland.
44. International Organization for Standardization. 2006. Susceptibility Testing of Infectious Agents and Evalutaion of Performance of Antimicrobial Susceptibility Devices, part 2. Evaluation of Performance of Antimicrobial Susceptibility Test Devices, vol. ISO/DIS 20776-2. International Organization for Standardization, Geneva, Switzerland.
45. Japanese Society for Chemotherapy. 1993. Report of the Committee for Japanese Standards for Antimicrobial Susceptibility Testing for Bacteria. Chemotherapy 41:183-189.
46. Japanese Society for Chemotherapy. 1990. Report of the Committee for Japanese Standards for Antimicrobial Susceptibility Testing for Bacteria. Chemotherapy 38:102-105.
47. Jevitt, L. A., G. M. Thorne, M. M. Traczewski, R. N. Jones, J. E. McGowan, Jr., F. C. Tenover, and S. D. Brown. 2006. Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non- daptomycin-susceptible Staphylococcus aureus isolates. J. Clin. Microbiol. 44:3098-3104.
48. Jorgensen, J. H. 1993. Selection criteria for an antimicrobial susceptibility testing system. J. Clin. Microbiol. 31:2841-2844.
49. Jorgensen, J. H. 1993. Selection of antimicrobial agents for routine testing in a clinical microbiology laboratory. Diagn. Microbiol. Infect. Dis. 16:245-249.
50. Jorgensen, J. H., and M. J. Ferraro. 1998. Antimicrobial susceptibility testing: general principles and contemporary practices. Clin. Infect. Dis. 26:973-980.
51. Jorgensen, J. H., J. M. Swenson, F. C. Tenover, M. J. Ferraro, J. A. Hindler, and P. R. Murray. 1994. Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J. Clin. Microbiol. 32:2448-2459.
52. Kahlmeter, G., D. F. Brown, F. W. Goldstein, A. P. MacGowan, J. W. Mouton, I. Odenholt, A. Rodloff, C. J. Soussy, M. Steinbakk, F. Soriano, and O. Stetsiouk. 2006. European Committee on Antimicrobial Susceptibility Testing (EUCAST) technical notes on antimicrobial susceptibility testing. Clin. Microbiol. Infect. 12:501-503.
53. King, A., and D. F. Brown. 2001. Quality assurance of antimicrobial susceptibility testing by disc diffusion. J. Antimicrob. Chemother. 48(Suppl. 1):71-76.
54. Lewis, J. S., II, and J. H. Jorgensen. 2005. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin. Infect. Dis. 40:280-285.
55. Lewis, J. S., II, A. Owens, J. Cadena, K. Sabol, J. E. Patterson, and J. H. Jorgensen. 2005. Emergence of dapto- mycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrob. Agents Chemother. 49:1664-1665.
56. Li, X. Z. 2005. Quinolone resistance in bacteria: emphasis on plasmid-mediated mechanisms. Int. J. Antimicrob. Agents 25:453-463.
57. MacGowan, A. P., and R. Wise. 2001. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. J. Antimicrob. Chemother. 48(Suppl. 1):17-28.
58. McDermott, S. N., and T. F. Hartley. 1989. New datum handling methods for the quality control of antibiotic solutions and plates used in the antimicrobial susceptibility test. J. Clin. Microbiol. 27:1814-1825.
59. Medeiros, A. A., and J. Crellin. 2000. Evaluation of the Sirscan automated zone reader in a clinical microbiology laboratory. J. Clin. Microbiol. 38:1688-1693.
60. Members of the SFM Antibiogram Committee. 2003. Comite de l'Antibiogramme de la Societe Francaise de Microbiologie report 2003. Int. J. Antimicrob. Agents 21:364-391.
61. Metzler, C. M., and R. M. DeHaan. 1974. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J. Infect. Dis. 130:588-594.
62. Olsson-Liljequist, B., P. Larsson, M. Walder, and H. Miorner. 1997. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand. J. Infect. Dis. Suppl. 105:13-23.
63. Pfaller, M. A., and R. N. Jones. 2006. Performance accuracy of antibacterial and antifungal susceptibility test methods: report from the College of American Pathologists Microbiology Surveys Program (2001-2003). Arch. Pathol. Lab. Med. 130:767-778.
64. Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile b-lactamases. Clin. Microbiol. Rev. 20:440-458.
65. Ringertz, S., B. Olsson-Liljequist, G. Kahlmeter, and G. Kronvall. 1997. Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance. Scand. J. Infect. Dis. Suppl. 105:8-12.
66. Rosenberg, J., F. C. Tenover, J. Wong, W. Jarvis, and D. J. Vugia. 1997. Are clinical laboratories in California accurately reporting vancomycin-resistant enterococci? J. Clin. Microbiol. 35:2526-2530.
67. Sahm, D. F., C. N. Baker, R. N. Jones, and C. Thornsberry. 1984. Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis. J. Clin. Microbiol. 20:561-567.
68. Steers, E., E. L. Foltz, B. S. Graves, and H. J. Suriano. 1959. Comparison of bacterial susceptibility to antibiotics as determined by the plate dilution method and by the disc method. Antibiot. Annu. 7:604-613.
69. Swedish Reference Group for Antibiotics. 1981. A revised system for antibiotic sensitivity testing. Scand. J. Infect. Dis. 13:148-152.
70. Swenson, J. M., K. F. Anderson, D. R. Lonsway, A. Thompson, S. K. McAllister, B. M. Limbago, R. B. Carey, F. C. Tenover, and J. B. Patel. 2009. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus. J. Clin. Microbiol. 47:2013-2017.
71. Swenson, J. M., W. B. Brasso, M. J. Ferraro, D. J. Hardy, C. C. Knapp, D. Lonsway, S. McAllister, L. B. Reller, H. S. Sader, D. Shortridge, R. Skov, M. P. Weinstein, B. L. Zimmer, and J. B. Patel. 2009. Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp. J. Clin. Microbiol. 47:1902-1905.
72. Swenson, J. M., and F. C. Tenover. 2005. Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp. J. Clin. Microbiol. 43:3818-3823.
73. Tenover, F. C., M. V. Lancaster, B. C. Hill, C. D. Steward, S. A. Stocker, G. A. Hancock, C. M. O'Hara, S. K. McAllister, N. C. Clark, and K. Hiramatsu. 1998. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J. Clin. Microbiol. 36:1020-1027.
74. Tenover, F. C., and L. C. McDonald. 2005. Vancomycin- resistant staphylococci and enterococci: epidemiology and control. Curr. Opin. Infect. Dis. 18:300-305.
75. Tenover, F. C., J. M. Swenson, C. M. O'Hara, and S. A. Stocker. 1995. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J. Clin. Microbiol. 33:1524-1527.
76. Thornsberry, C., and L. K. McDougal. 1983. Successful use of broth microdilution in susceptibility tests for methicillin- resistant (heteroresistant) staphylococci. J. Clin. Microbiol. 18:1084-1091.
77. Toohey, M., G. Francis, and N. Stingemore. 1990. Variation in Iso-Sensitest agar affecting b-lactam testing. Newsl. Antimicrob. Spec. Interest Group Aust. Soc. Microbiol. 6:6-8.
78. Turnidge, J., G. Kahlmeter, and G. Kronvall. 2006. Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values. Clin. Microbiol. Infect. 12:418-425.
79. Turnidge, J. D., and J. M. Bell. 2005. Antimicrobial susceptibility on solid media, p. 8-60. In V. Lorien (ed.), Antibiotics in Laboratory Medicine, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
80. Ward, P., S. Palladino, B. McLaren, R. J. Rathur, and J. C. Looker. 1993. The effect of increased agar concentration in susceptibility testing media on MICs of antimicrobials for gramnegative bacilli. J. Antimicrob. Chemother. 31:1005-1007.
81. Ward, P. B., S. Palladino, J. C. Looker, and P. Feddema. 1993. p-Nitrophenylglycerol in susceptibility testing media alters the MICs of antimicrobials for Pseudomonas aeruginosa. J. Antimicrob. Chemother. 31:489-496.
82. Wheat, P. F. 1989. The agar-dilution susceptibility technique: past and present. Clin. Microbio. Newsl. 11:164-166.
83. Williams, J. D. 1990. Prospects for standardisation of methods and guidelines for disc susceptibility testing. Eur. J. Clin. Microbiol. Infect. Dis. 9:496-501.